Publications (187) Manuel Fuentes García publications

filter_list

2025

  1. Assessment of Humoral Response at SARS-CoV-2 Infection by Multipronged Functional Proteomics Approaches

    Journal of Proteome Research, Vol. 24, Núm. 2, pp. 515-525

  2. Insights into podophyllotoxin lactone features: New cyclolignans as potential dual tubulin-topoisomerase II inhibitors

    Archiv der Pharmazie, Vol. 358, Núm. 1

2024

  1. Crucial Parameters for Immunopeptidome Characterization: A Systematic Evaluation

    International Journal of Molecular Sciences, Vol. 25, Núm. 17

  2. Functional proteomics based on protein microarray technology for biomedical research

    Advances in Protein Chemistry and Structural Biology (Academic Press Inc.), pp. 49-65

  3. Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells

    Science Immunology, Vol. 9, Núm. 91

  4. Podophyllic Aldehyde, a Podophyllotoxin Derivate, Elicits Different Cell Cycle Profiles Depending on the Tumor Cell Line: A Systematic Proteomic Analysis

    International Journal of Molecular Sciences, Vol. 25, Núm. 9

  5. Potential protein biomarkers in saliva for detection of frailty syndrome by targeted proteomics

    Mechanisms of Ageing and Development, Vol. 221

2023

  1. A Longitudinal Study of Individual Radiation Responses in Pediatric Patients Treated with Proton and Photon Radiotherapy, and Interventional Cardiology: Rationale and Research Protocol of the HARMONIC Project

    International Journal of Molecular Sciences, Vol. 24, Núm. 9

  2. Enhancement of Tumor Cell Immunogenicity and Antitumor Properties Derived from Platinum-Conjugated Iron Nanoparticles

    Cancers, Vol. 15, Núm. 12

  3. Exploring High-Throughput Immunoassays for Biomarker Validation in Rheumatic Diseases in the Context of the Human Proteome Project

    Journal of Proteome Research, Vol. 22, Núm. 4, pp. 1105-1115

  4. Improving Properties of Podophyllic Aldehyde-Derived Cyclolignans: Design, Synthesis and Evaluation of Novel Lignohydroquinones, Dual-Selective Hybrids against Colorectal Cancer Cells

    Pharmaceutics, Vol. 15, Núm. 3

  5. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

  6. Systematic Evaluation of Antigenic Stimulation in Chronic Lymphocytic Leukemia: Humoral Immunity as Biomarkers for Disease Evolution

    Cancers, Vol. 15, Núm. 3

  7. Translational research into frailty from bench to bedside: Salivary biomarkers for inflammaging

    Experimental Gerontology, Vol. 171

2022

  1. A quantitative systems approach to define novel effects of tumour p53 mutations on binding oncoprotein mdm2

    International Journal of Molecular Sciences, Vol. 23, Núm. 1

  2. Comprehensive and systematic characterization of multi-functionalized cisplatin nano-conjugate: from the chemistry and proteomic biocompatibility to the animal model

    Journal of Nanobiotechnology, Vol. 20, Núm. 1

  3. Deciphering Biomarkers for Leptomeningeal Metastasis in Malignant Hemopathies (Lymphoma/Leukemia) Patients by Comprehensive Multipronged Proteomics Characterization of Cerebrospinal Fluid

    Cancers, Vol. 14, Núm. 2

  4. Multi-laboratory experiment PME11 for the standardization of phosphoproteome analysis

    Journal of Proteomics, Vol. 251

  5. Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration

    Cancers, Vol. 14, Núm. 16

  6. SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS

    Frontiers in Immunology, Vol. 13